Xoma | XOMA - Trade Creditors


Xoma reported $2.65M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Agenus USD 71.08M 11.9M Mar/2026
Agios Pharmaceuticals USD 13.75M 4.61M Mar/2026
Ardelyx USD 28.2M 8.96M Mar/2026
aTyr Pharma USD 2.76M 52.32M Mar/2026
BioMarin Pharmaceutical USD 793.15M 34.12M Mar/2026
Celldex Therapeutics USD 10.36M 9.18M Mar/2026
Curis USD 5.61M 1.52M Dec/2025
Eli Lilly USD 5.03B 350M Mar/2026
Emergent BioSolutions USD 112.2M 500K Dec/2023
Incyte USD 228.62M 1.41B Mar/2026
MacroGenics USD 4.29M 500K Mar/2026
Novartis USD 4.32B 134M Mar/2026
Novartis USD 4.46B 99M Dec/2025
Pfizer USD 4.51B 734M Mar/2026
Prothena USD 4.3M 1.58M Mar/2026
Regeneron Pharmaceuticals USD 1.03B 4.81B Mar/2026
Xoma USD 2.65M 1.52M Sep/2025